174 related articles for article (PubMed ID: 16193387)
1. Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Hahn BM; Schrell UM; Sauer R; Fahlbusch R; Ganslandt O; Grabenbauer GG
J Neurooncol; 2005 Sep; 74(2):157-65. PubMed ID: 16193387
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.
Chamberlain MC; Johnston SK
J Neurooncol; 2011 Sep; 104(3):765-71. PubMed ID: 21318318
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma.
Chamberlain MC
J Neurooncol; 2012 Apr; 107(2):315-21. PubMed ID: 22127733
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
7. Treatment of high risk or recurrent meningiomas with hydroxyurea.
Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
[TBL] [Abstract][Full Text] [Related]
8. [Hydroxyurea treatment for unresectable meningioma].
Fuentes S; Chinot O; Dufour H; Paz-Paredes A; Métellus P; Barrie-Attarian M; Grisoli F
Neurochirurgie; 2004 Sep; 50(4):461-7. PubMed ID: 15547484
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results.
Sajja R; Barnett GH; Lee SY; Harnisch G; Stevens GH; Lee J; Suh JH
Technol Cancer Res Treat; 2005 Dec; 4(6):675-82. PubMed ID: 16292888
[TBL] [Abstract][Full Text] [Related]
10. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
11. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
Wenkel E; Thornton AF; Finkelstein D; Adams J; Lyons S; De La Monte S; Ojeman RG; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1363-70. PubMed ID: 11121635
[TBL] [Abstract][Full Text] [Related]
12. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
14. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.
Milker-Zabel S; Zabel-du Bois A; Huber P; Schlegel W; Debus J
Strahlenther Onkol; 2006 Nov; 182(11):635-40. PubMed ID: 17072520
[TBL] [Abstract][Full Text] [Related]
15. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
[TBL] [Abstract][Full Text] [Related]
16. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protonthérapie d'Orsay.
Noël G; Habrand JL; Mammar H; Haie-Meder C; Pontvert D; Dederke S; Ferrand R; Beaudré A; Gaboriaud G; Boisserie G; Mazeron JJ
Strahlenther Onkol; 2002 Sep; 178(9):480-5. PubMed ID: 12426833
[TBL] [Abstract][Full Text] [Related]
17. Non-resectable slow-growing meningiomas treated by hydroxyurea.
Loven D; Hardoff R; Sever ZB; Steinmetz AP; Gornish M; Rappaport ZH; Fenig E; Ram Z; Sulkes A
J Neurooncol; 2004; 67(1-2):221-6. PubMed ID: 15072471
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea chemotherapy in the treatment of meningiomas.
Newton HB
Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
[TBL] [Abstract][Full Text] [Related]
20. Stereotactically guided conformal radiotherapy for meningiomas.
Alheit H; Saran FH; Warrington AP; Rosenberg I; Perks J; Jalali R; Shepherd S; Beardmore C; Baumert B; Brada M
Radiother Oncol; 1999 Feb; 50(2):145-50. PubMed ID: 10368037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
